BROOKLYN, NY – Synthpop AI, a leading innovator in artificial intelligence solutions for the healthcare industry, is thrilled to announce the appointment of Chip Smith as Senior Director of Durable Medical Equipment (DME). With more than two decades of leadership and expertise in the DME industry, Chip brings a wealth of experience and insight to Synthpop's growing team.
Chip has been a leader and passionate supporter of the DME industry throughout his career. He founded and served as President of Restoration Medical, a sleep and respiratory-focused DME company. He later sold Restoration Medical to Adapt in 2019, where he held several key positions before joining Synthpop AI in October 2023. His extensive background includes expertise in sleep and respiratory care, making him uniquely positioned to help lead Synthpop's innovative solutions in the home care space.
"The advancements our AI technology brings to the home care industry will be revolutionary for both improved patient care and better profitability," said Chip Smith. "I'm excited to be part of the Synthpop team, where we'll leverage cutting-edge AI to reshape how we approach DME and ultimately improve the quality of life for patients and providers alike."
As the Senior Director of DME, Chip will lead the development and implementation of innovative AI-driven solutions that aim to enhance patient outcomes, streamline operations, and drive profitability in the DME sector. His appointment underscores Synthpop's commitment to leveraging AI to transform the future of healthcare.
"We are delighted to welcome Chip Smith to Synthpop AI," said Elad Ferber, CEO of Synthpop. "His vision and extensive industry experience align perfectly with our mission and values. Chip’s experience and depth of understanding DME processes is unparalleled. He is an asset on the continuum of activities we perform - from product definitions and customer processes, through customer success, conveying the value of our AI agents to prioritizing engineering work based on customer needs. We believe his leadership will be instrumental in driving the development of solutions that will profoundly impact the DME landscape."
Synthpop AI is dedicated to redefining healthcare through advanced AI solutions that boost efficiency and accuracy healthcare administration without compromising security. The company has made rapid progress in development and sales since inception in 2023 and just closed their second funding round. Thanks to customer traction, they have thousands of real examples to test and develop their methods with while receiving immediate customer feedback.
With Chip's appointment, Synthpop is poised to further enhance its offerings in the DME sector, from sleep and respiratory to CGM, mobility, and even diagnostic testing (IDTF). By leveraging artificial intelligence to address complex challenges, Synthpop AI aims to improve patient outcomes and transform the healthcare landscape.
To contact Chip directly, email [email protected]
About Synthpop
Synthpop’s AI agents perform complex healthcare administrative tasks - from referral sorting and processing, to instantly validating medical orders and prescriptions by referencing payor and clinical guidelines. Synthpop's AI Agents can navigate complex payor phone trees, freeing up. your team to perform more critical tasks. Following Standard Operating Procedures, Synthpop’s agents are accurate and tireless, allowing you to scale your business to get more patients the care they are prescribed. Synthpop leverages multimodal Large Language Models (LLMs) to streamline healthcare, one workflow at a time.
For more information, please email [email protected]
Synthpop 1 minute Explainer Video
